GYRE
Income statement / Annual
Last year (2023), Gyre Therapeutics, Inc.'s total revenue was $113.45 M,
an increase of 14,188.41% from the previous year.
In 2023, Gyre Therapeutics, Inc.'s net income was -$92.93 M.
See Gyre Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$113.45 M
|
$794,000.00
|
$7.34 M
|
$20.95 M
|
$0.00
|
$6,000.00
|
$1.02 M
|
$399,000.00
|
$1.75 M
|
$275,000.00
|
| Cost of Revenue |
$4.64 M |
$798,000.00 |
$7.38 M |
$9.16 M |
$43.86 M |
$21.47 M |
$12.85 M |
$10.56 M |
$5.96 M |
$5.27 M |
| Gross Profit |
$108.81 M |
-$4,000.00 |
-$42,000.00 |
$11.79 M |
-$43.86 M |
-$21.47 M |
-$11.83 M |
-$10.16 M |
-$4.21 M |
-$4.99 M |
| Gross Profit Ratio |
0.96 |
-0.01 |
-0.01 |
0.56 |
0 |
-3578 |
-11.62 |
-25.45 |
-2.4 |
-18.15 |
| Research and Development
Expenses |
$13.78 M
|
$13.04 M
|
$68.89 M
|
$52.98 M
|
$43.86 M
|
$21.47 M
|
$12.85 M
|
$11.56 M
|
$5.96 M
|
$19.50 M
|
| General & Administrative
Expenses |
$14.66 M
|
$17.37 M
|
$18.96 M
|
$16.18 M
|
$13.42 M
|
$12.35 M
|
$9.99 M
|
$9.26 M
|
$9.59 M
|
$10.17 M
|
| Selling & Marketing
Expenses |
$61.16 M
|
$54.24 M
|
$44.65 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$75.82 M
|
$17.37 M
|
$18.96 M
|
$16.18 M
|
$13.42 M
|
$12.35 M
|
$9.99 M
|
$9.26 M
|
$9.59 M
|
$10.17 M
|
| Other Expenses |
$86.44 M |
-$517,000.00 |
-$78,000.00 |
$568,000.00 |
-$46,000.00 |
$1.65 M |
$261,000.00 |
$86,000.00 |
$0.00 |
$318,000.00 |
| Operating Expenses |
$89.60 M |
$30.40 M |
$87.85 M |
$69.16 M |
$57.28 M |
$33.83 M |
$22.84 M |
$20.82 M |
$15.55 M |
$29.67 M |
| Cost And Expenses |
$180.68 M |
$31.20 M |
$95.23 M |
$78.32 M |
$57.28 M |
$33.83 M |
$22.84 M |
$20.82 M |
$15.55 M |
$29.67 M |
| Interest Income |
$0.00 |
$537,000.00 |
$39,000.00 |
$1.13 M |
$2.10 M |
$3.77 M |
$261,000.00 |
$3.47 M |
$518,000.00 |
$585,000.00 |
| Interest Expense |
$0.00 |
$717,000.00 |
-$220,958.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$1.48 M |
$23,000.00 |
| Depreciation &
Amortization |
$1.11 M
|
$1.13 M
|
$290,000.00
|
$138,000.00
|
$146,000.00
|
$149,000.00
|
$173,000.00
|
$389,000.00
|
$470,000.00
|
$351,000.00
|
| EBITDA |
$20.33 M
|
$10.33 M
|
-$87.60 M
|
-$57.37 M
|
-$57.28 M
|
-$33.82 M
|
-$21.82 M
|
-$16.95 M
|
-$12.81 M
|
-$29.71 M
|
| EBITDA Ratio |
0.18 |
-65.68 |
-11.94 |
-2.74 |
0 |
-5637 |
-21.44 |
-42.47 |
-7.32 |
-103.49 |
| Operating Income Ratio
|
-0.59
|
-10.85
|
-11.98
|
-2.74
|
0
|
-5637
|
-21.44
|
-51.17
|
-7.89
|
-108.05
|
| Total Other
Income/Expenses Net |
-$9.74 M
|
$209,000.00
|
-$39,000.00
|
$1.13 M
|
$2.10 M
|
$3.77 M
|
$261,000.00
|
$3.47 M
|
-$960,000.00
|
$575,000.00
|
| Income Before Tax |
-$76.97 M |
-$7.89 M |
-$87.93 M |
-$56.24 M |
-$55.18 M |
-$30.06 M |
-$21.56 M |
-$16.95 M |
-$14.76 M |
-$29.14 M |
| Income Before Tax Ratio
|
-0.68
|
-9.94
|
-11.98
|
-2.68
|
0
|
-5009.17
|
-21.18
|
-42.47
|
-8.44
|
-105.96
|
| Income Tax Expense |
$8.52 M |
$348,000.00 |
-$39,000.00 |
-$699,000.00 |
-$2.29 M |
$3.77 M |
-$173,000.00 |
$3.08 M |
$518,000.00 |
$3.48 M |
| Net Income |
-$92.93 M |
$2.30 M |
-$87.93 M |
-$55.54 M |
-$52.89 M |
-$30.06 M |
-$21.56 M |
-$16.95 M |
-$14.76 M |
-$32.62 M |
| Net Income Ratio |
-0.82 |
2.9 |
-11.98 |
-2.65 |
0 |
-5009.17 |
-21.18 |
-42.47 |
-8.44 |
-118.63 |
| EPS |
-1.41 |
0.0362 |
-2.87 |
-2.9 |
-4.41 |
-2.68 |
-6.3 |
-21.76 |
-49.99 |
-101.4 |
| EPS Diluted |
-1.41 |
0.03 |
-2.87 |
-2.9 |
-4.41 |
-2.68 |
-6.3 |
-21.76 |
-49.99 |
-101.4 |
| Weighted Average Shares
Out |
$65.83 M
|
$76.74 M
|
$30.64 M
|
$19.18 M
|
$12.00 M
|
$11.21 M
|
$3.42 M
|
$778,780.00
|
$295,272.00
|
$321,719.00
|
| Weighted Average Shares
Out Diluted |
$65.83 M
|
$75.69 M
|
$30.64 M
|
$19.18 M
|
$12.00 M
|
$11.21 M
|
$3.42 M
|
$778,780.00
|
$295,272.00
|
$321,719.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
